Strategies for Optimizing Glycemic Control and Cardiovascular Prognosis in Patients With Type 2 Diabetes Mellitus

O'Keefe, James H.; Abuannadi, Mohammad; Lavie, Carl J.; Bell, David S. H.
February 2011
Mayo Clinic Proceedings;Feb2011, Vol. 86 Issue 2, p128
Academic Journal
Type 2 diabetes mellitus (DM) is a major cardiovascular (CV) risk factor and, as such, is considered a coronary artery disease risk equivalent. Although glycemic control is associated with decreased CV events epidemiologically, many prospective clinical trials have failed to conclusively demonstrate that aggressive glycemic control improves the CV prognosis of patients with type 2 DM, especially those with long-standing DM. Many therapies for type 2 DM with widely divergent mechanisms of action are available. Some of these drugs, in addition to their glucose-lowering actions, have properties that may reduce or Increase CV events. Agents that lower both insulin resistance and postprandial hyperglycemia while at the same time avoiding hypoglycemia may be beneficial for CV health. This article reviews the evidence regarding the use of these agents and appropriate glycemic control targets for Improving the adverse CV prognosis associated with type 2 DM. We conducted a systematic review of English articles using MEDLINE and the Coéhrane Controlled Trials Register (1970-2010) using the following search terms: cardiovascular disease, randomized trials, hypoglycemia, and Insulin resistance.


Related Articles

  • Pleiotropic Effects of Rimonabant: Clinical Implications. Despr�s, Jean-Pierre // Current Pharmaceutical Design;2/11/2009, Vol. 15 Issue 5, p553 

    Abdominal obesity (high waist circumference) is more strongly associated with cardiovascular disease and type 2 diabetes than generalized adiposity (high body mass index). Recent research has highlighted the role of chronic overactivation of the endogenous endocannabinoid system, acting through...

  • ACDC/Adiponectin Polymorphisms Are Associated With Severe Childhood and Adult Obesity. Bouatia-Naji, Nabila; Meyre, David; Lobbens, Stéphane; Séron, Karin; Fumeron, Frédéric; Balkau, Beverley; Heude, Barbara; Jouret, Béatrice; Scherer, Philipp E.; Dina, Christian; Weill, Jacques; Froguel, Philippe // Diabetes;Feb2006, Vol. 55 Issue 2, p545 

    Common single nucleotide polymorphisms (SNPs) in the ACDC adiponectin encoding gene have been associated with insulin resistance and type 2 diabetes in several populations. Here, we investigate the role of SNPs -11,377C>G, -11,391G>A, +45T>G, and +276G>T in 2,579 French Caucasians (1,229...

  • Mother Load A Lucrative Investment Rainy Day Reaction. Barrett, Julia R. // Environmental Health Perspectives;Jul2009, Vol. 117 Issue 7, pA310 

    The article focuses on the research regarding the chronic exposure of arsenic to cause an increased risk of type two diabetes mellitus. The research shows that arsenic can enhance type two diabetes by increasing insulin resistance and impaired insulin production. Meanwhile, it also suggests that...

  • Does the Metabolic Syndrome Exist? Grundy, Scott M. // Diabetes Care;Jul2006, Vol. 29 Issue 7, p1689 

    The article examines whether the well-established clustering of metabolic risk factors underlying both cardiovascular disease and type 2 diabetes deserve to be called a syndrome and, even if the metabolic syndrome can be accepted as a concept, whether the concept has matured enough to be...

  • The Metabolic Syndrome (Emperor) Wears No Clothes. Kahn, Richard // Diabetes Care;Jul2006, Vol. 29 Issue 7, p1693 

    The article examines whether there is a biological basis for integration of the metabolic syndrome into concepts of insulin resistance, pre-diabetes, and type 2 diabetes. It infers that the presence of the syndrome is associated with a higher risk of diabetes or cardiovascular disease (CVD)....

  • Calpain-10 Not Influential on PCOS. McCarthy, Mark I. // Fertility Weekly;9/9/2002, p2 

    Reports on the lack of connection between a variation in the type 2 diabetes susceptibility gene (Calpain-10) and a higher risk for developing polycystic ovarian syndrome (PCOS). Exhibition of PCOS patients of abnormal endocrine responses, infertility and insulin resistance; Lack of link seen...

  • Impairment of cerebrovascular reactivity is proportional to degree of insulin resistance in patients with type 2 diabetes. Jaryal, A.; Prakash, K.; Chandran, D. S.; Khadgawat, R.; Deepak, K. // Proceedings of the Physiological Society;2013, p939P 

    Increased risk of cerebrovascular diseases in type 2 diabetes mellitus is associated with impaired cerebrovascular reactivity (CVR) as well as the degree of insulin resistance. Recent studies in healthy human subjects have shown that CVR measured in response to hypercapneic stimulus is...

  • The role of insulin resistance in type 2 diabetes. Fisher, Miles // Pulse;3/15/2004, Vol. 64 Issue 11, p69 

    Discusses the fundamental role of insulin resistance in the development of type 2 diabetes in Great Britain. Independent risk factor for cardiovascular disease; Significance of the predictor of disease in primary care.

  • Pathophysiology of Platelet Resistance to Anti-Aggregating Agents in Insulin Resistance and Type 2 Diabetes: Implications for Anti-Aggregating Therapy. Anfossi, Giovanni; Trovati, Mariella // Cardiovascular & Hematological Agents in Medicinal Chemistry;2006, Vol. 4 Issue 2, p111 

    The insulin resistance syndrome, which presents among its many facets obesity and type 2 diabetes mellitus, is a major risk factor for cardiovascular events. Thus, therapeutic guidelines recommend multifactorial treatment programs including, especially in the presence of type 2 diabetes,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics